Performance of the OraQuick rapid antibody test for diagnosis of human immunodeficiency virus type 1 infection in patients with various levels of exposure to highly active antiretroviral therapy.

@article{OConnell2003PerformanceOT,
  title={Performance of the OraQuick rapid antibody test for diagnosis of human immunodeficiency virus type 1 infection in patients with various levels of exposure to highly active antiretroviral therapy.},
  author={Robert J. O'Connell and Teresa M Merritt and Jennifer A Malia and Thomas C Vancott and Matthew J. Dolan and Hassan Zahwa and William L. Bradley and Bernard M. Branson and Nelson L Michael and Caroline C De Witt},
  journal={Journal of clinical microbiology},
  year={2003},
  volume={41 5},
  pages={2153-5}
}
With oral mucosal transudate and serum samples from 101 human immunodeficiency virus type 1 (HIV-1)-infected subjects and 100 HIV-1-negative volunteers, the OraQuick HIV-1 test demonstrated 100% specificity and 96% sensitivity. Four false-negative subjects, who were characterized by early initiation of effective antiretroviral therapy, demonstrated waning serum anti-gp41 titers and Western blot band intensities. 
Recent Discussions
This paper has been referenced on Twitter 5 times over the past 90 days. VIEW TWEETS
33 Citations
0 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 33 extracted citations

Similar Papers

Loading similar papers…